Showing 1 - 10 of 16 Results
Published July 2001. Revised August 2006.
Explores the latest research on anabolic steroid use, including health consequences of steroid abuse, the effects it can have on behavior, prevention research, and effective treatment approaches.
Published May 1999. Revised May 2016.
Describes the latest research findings on cocaine, exploring the scope of abuse in the U.S., its potential long- and short-term health effects, maternal cocaine use, and treatment approaches.
Published December 2008. Revised September 2010.
Introduces a report that focuses on the topic of comorbid drug use disorders and other mental illnesses, a research priority for NIDA.
Published March 2001. Revised February 2015.
Offers the latest research findings on hallucinogens and dissociative drugs, describing what they are, how they are abused, and basic facts about different drugs within this classification of drugs.
Published October 1997. Revised November 2014.
Offers the latest scientific information on heroin use and its consequences as well as treatment options available for those struggling with heroin addiction.
Published March 2006. Revised July 2012.
Explores the link between drug abuse and HIV/AIDS and discusses treatment options, populations most at risk, trends in HIV/AIDS, and ways to counter these trends.
Published May 1999. Revised July 2012.
Provides scientific research on the nature and extent of inhalant abuse, its potential health consequences, and hazards of chemicals found in commonly abused inhalants.
Published October 2002. Revised April 2017.
Explores the latest research on marijuana, including the scope of marijuana use in the U.S., health consequences, its effects on everyday activities, and available treatments.
Published March 2006.
Describes the science behind MDMA (ecstasy) abuse, including what it does to the brain, whether it is addictive, and the latest research regarding prevention and treatment of MDMA.
Published May 2017.
Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone.